Women's Health News

RSS

VBL Therapeutics reports positive results from VB-111 Phase 1/2a study in recurrent platinum-resistant Müllerian cancer

VBL Therapeutics, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced positive interim results from an investigator-initiated, Phase 1/2a trial of multiple dose VB-111 in recurrent platinum-resistant Müllerian (ovarian) cancer.

2 Jun 2015

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Astellas Pharma Inc. announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single agent for the treatment of advanced androgen receptor (AR) positive, triple-negative breast cancer (TNBC) were presented during an oral abstracts session at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

2 Jun 2015

MorphoSys announces updated clinical data on its proprietary drug candidate MOR208

MorphoSys AG today announced updated clinical data on its proprietary drug candidate MOR208. MOR208 is a potent anti-CD19 antibody with a proprietary modification to the Fc portion that is being developed to treat B-cell malignancies.

2 Jun 2015

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company’s versatile Vaxiclase platform.

2 Jun 2015

Invitae introduces new patient pay program to make genetic testing more affordable, accessible

Invitae Corporation, a genetic information company, announced today the launch of its new patient pay price for its full menu of genetic tests at $475 per indication.

2 Jun 2015

Babson College's WIN Lab to host Women’s Entrepreneurship Summer Soiree on June 4, 2015

Babson College's Women Innovating Now (WIN) Lab will host its Women's Entrepreneurship Summer Soiree at the Fields Corner Business Lab in Boston on Thursday, June 4, 2015.

1 Jun 2015

FDA clears ADXS-HPV plus epacadostat IND for HPV-associated cervical cancer Phase 2 study

Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.

1 Jun 2015

Investigational anti-cancer agent ONT-380 shows activity against HER2+ breast cancer

Promising clinical trial results presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show activity of the investigational anti-cancer agent ONT-380 against HER2+ breast cancer, in one case specifically against brain metastases and in another case in overall survival of heavily pretreated HER2+ breast cancer patients.

1 Jun 2015

New $2.6 million grant targets expectant mothers requiring cesarean section in Kenya

In an especially underserved region of western Kenya, expectant mothers requiring cesarean section are the focus of a new $2.6 million grant to Vanderbilt University Medical Center (VUMC), Kenya's AIC Kijabe Hospital and the Kenya-based Center for Public Health and Development.

1 Jun 2015

Alternative rehabilitation program for women diagnosed with diastasis recti

A series of online exercises and on demand curriculum is now available for women battling a not so well-known condition called diastasis recti. Founder, Raintree Sumazin, retired ballerina, pilates and yoga instructor, and certified holistic health counselor, brought this program to life after herself recovering from 8 finger diagnosis of the condition.

1 Jun 2015

Norwegian Biotechnology Council recommends that egg donation be made legal in Norway

More than 5 million children in Europe have been born as a result of assisted reproductive technologies, yet many European countries, including Norway, have regulations that restrict different aspects of these technologies.

1 Jun 2015

Palbociclib drug shows promise in women with HR+ metastatic breast cancer

Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.

30 May 2015

Removing more tissue during partial mastectomy reduces need for second surgery in breast cancer patients

Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.

30 May 2015

Penn researchers to present clinical data at 2015 ASCO Annual Meeting

Researchers from the Abramson Cancer Center of the University of Pennsylvania and Penn's Perelman School of Medicine will present results from several clinical trials and other key studies during the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting from May 29 through June 2.

30 May 2015

Tennessee physician offers innovative painless procedure for postmenopausal patients

Dr. Yair Walzer has added a leading edge treatment to his practice to resolve vaginal health issues often caused by menopause. The MonaLisa Touch™, an in-office procedure that is virtually painless and requires no anesthesia, received FDA clearance in 2014.

30 May 2015

B Floral raises awareness for Ovarian Cancer Research Fund

From Los Angeles to the Hamptons, New York's premiere floral event design company, B Floral, is giving back and helping raise awareness for Ovarian Cancer Research Fund (OCRF).

30 May 2015

Study shows increased sexual dysfunction in women following gynecologic cancer treatment

A University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 shows decreased sexual activity in women following treatment for gynecologic cancers, down from 6.1-6.8 times per month before treatment to 2.6-4.9 times per month after treatment.

30 May 2015

Myriad Genetics to highlight new clinical studies on myRisk Hereditary Cancer test at ASCO 2015

Myriad Genetics, Inc. today announced it will highlight several new clinical studies on its myRisk Hereditary Cancer molecular diagnostic test at the 2015 American Society of Clinical Oncology annual meeting being held in Chicago, Ill.

30 May 2015

Merck signs in vitro fertilization deal with Genea Biomedx

Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced the global collaboration agreement with the fertility technologies expert Genea Biomedx, an Australian company, dedicated to advancing fertility science and helping couples create families. With this partnership, Merck Serono, the biopharmaceutical business of Merck, and global market leader in drugs for Assisted Reproductive Treatment (ART), receives global marketing and commercialization rights to Genea Biomedx’s product portfolio.

30 May 2015

Larger studies needed to validate multigene testing for prediction of breast cancer risk

While advances in technology have made multigene testing, or "panel testing," for genetic mutations that increase the risk of breast or other cancers an option, authors of a review published today in the New England Journal of Medicine say larger studies are needed in order to provide reliable risk estimates for counseling these patients.

29 May 2015

Women's Health News

VBL Therapeutics reports positive results from VB-111 Phase 1/2a study in recurrent platinum-resistant Müllerian cancer

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

MorphoSys announces updated clinical data on its proprietary drug candidate MOR208

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

Invitae introduces new patient pay program to make genetic testing more affordable, accessible

Babson College's WIN Lab to host Women’s Entrepreneurship Summer Soiree on June 4, 2015

FDA clears ADXS-HPV plus epacadostat IND for HPV-associated cervical cancer Phase 2 study

Investigational anti-cancer agent ONT-380 shows activity against HER2+ breast cancer

New $2.6 million grant targets expectant mothers requiring cesarean section in Kenya

Alternative rehabilitation program for women diagnosed with diastasis recti

Norwegian Biotechnology Council recommends that egg donation be made legal in Norway

Palbociclib drug shows promise in women with HR+ metastatic breast cancer

Removing more tissue during partial mastectomy reduces need for second surgery in breast cancer patients

Penn researchers to present clinical data at 2015 ASCO Annual Meeting

Tennessee physician offers innovative painless procedure for postmenopausal patients

B Floral raises awareness for Ovarian Cancer Research Fund

Study shows increased sexual dysfunction in women following gynecologic cancer treatment

Myriad Genetics to highlight new clinical studies on myRisk Hereditary Cancer test at ASCO 2015

Merck signs in vitro fertilization deal with Genea Biomedx

Larger studies needed to validate multigene testing for prediction of breast cancer risk

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News